AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 15 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 4.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,381,000 | -17.6% | 2,000,000 | 0.0% | 0.02% | -32.3% |
| Q4 2018 | $1,676,000 | +8.1% | 2,000,000 | 0.0% | 0.03% | +63.2% |
| Q3 2018 | $1,551,000 | -84.0% | 2,000,000 | -86.7% | 0.02% | -83.6% |
| Q2 2018 | $9,718,000 | -19.3% | 15,000,000 | 0.0% | 0.12% | -22.1% |
| Q1 2018 | $12,040,000 | +0.3% | 15,000,000 | 0.0% | 0.15% | -2.0% |
| Q4 2017 | $12,006,000 | -1.2% | 15,000,000 | 0.0% | 0.15% | +31.0% |
| Q3 2017 | $12,151,000 | -1.0% | 15,000,000 | 0.0% | 0.12% | -10.1% |
| Q2 2017 | $12,269,000 | -0.4% | 15,000,000 | 0.0% | 0.13% | -7.9% |
| Q1 2017 | $12,317,000 | +106.1% | 15,000,000 | +87.5% | 0.14% | +84.2% |
| Q4 2016 | $5,976,000 | – | 8,000,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,500,000 | $1,219,000 | 0.82% |
| EdgePoint Investment Group Inc. | 51,642,000 | $41,704,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,600,000 | $13,359,000 | 0.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 43,150,000 | $34,952,000 | 0.52% |
| Tekla Capital Management LLC | 13,000,000 | $10,303,000 | 0.37% |
| UBS OCONNOR LLC | 26,000,000 | $20,669,000,000 | 0.30% |
| Orbimed Advisors | 15,000,000 | $12,151,000 | 0.12% |
| Baker Brothers Advisors | 9,517,000 | $7,576,000 | 0.06% |
| CSS LLC/IL | 653,000 | $517,000 | 0.02% |
| Allianz Asset Management GmbH | 28,680,000 | $23,232,000 | 0.02% |